Stefan Norin
Vermögen: 2 740 $ am 31.05.2026
Vermögen: 2 740 $ am 31.05.2026
Stefan Norin currently works at Oncopeptides AB, as Chief Medical Officer from 2023.
Mr. Norin also formerly worked at Medivir AB, as Associate Director-Clinical Research & development from 2017 to 2019 and Karolinska University Hospital, as Head-Lymphosection.
Mr. Norin received his doctorate degree from Karolinska Institutet.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.03.2026 | 13’975 ( 0% ) | 2 740 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOPEPTIDES AB | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIVIR AB | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2019 |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Karolinska University Hospital
Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen